Hello again.
Thanks for your answer. It is hard to know what is going to happen.
I guess about Mac, well first they say no, and them they say yes. It doesn't really make any sense not to reach the endpoint and then go for it. I guess the most positive they can get is a new trial to confirm data. I guess that is why the share price is dropping. If you want to go for Zoptrex you might be better off after the meeting with the FDA because most likely it will be thumps down.
I guess the companies behavior only adds to the lack of confidence and send DD in the shades.
I don't understand your point about the 50 million. Isn't it ATM which gives the company the right to sell new shares up to the total amount of 50 million? Well, if they fail or have to do new trials they can raise the money through ATM, but it might be at a price of 1 dollar or even less. The new shares then add to the 13,5 mill shares.
For me the strongest point is that they have made partnership not with one , but as far as I remember, with four companies including China's biggest Sinopharm A-think. I guess they all have made heavy research before making partnership all though it has been a cheap deal with no upfront payment except for A-think. But they all have to make the effort and spend money, and I guess a quick way for Aezs to get Zoptrex to the marked in different parts of the world.
But if Zoptrex works, the sky is not the limit. The pipeline alone is worth tremendous and I guess the company will be a buyout target and we will be sitting on mars.
All the best and behavour like an insisting virgin! ( Danish joke)
